The paper presents the overlook on bismuth oxide nanoparticles as a potential material applied in medicine-related fields of science. First, the types of drug delivery systems are described. General properties of bismuth oxide are considered as well. The main part of article is devoted to bismuth oxide-based systems intended for drug delivery and medical imaging purposes. It has been confirmed by many scientists that bismuth oxide nanoparticles are a promising material for drug delivery systems and for enhancing the properties of other products in medical applications.
Similar content being viewed by others
References
G. Tiwari, R. Tiwari, B. Sriwastawa, et al., Int. J. Pharm. Investig., 2(1), 2 – 11 (2012).
V. Hearnden, V. Sankar, K. Hull, et al., Adv. Drug. Deliv. Rev., 64(1), 16 – 28 (2012).
N. Gulati and H. Gupta, Recent Pat. Drug Deliv. Formul., 5(2), 133 – 145 (2011).
A. Z. Alkilani, M. T. McCrudden, and R. F. Donnelly, Pharmaceutics, 7(4), 438 – 470 (2015).
M. Ibrahim and L. Garcia-Contreras, Ther. Deliv., 4(8), 1027 – 1045 (2013).
G. Kaptay, Int. J. Pharm., 430(1 – 2), 253 – 257 (2012).
A. Z. Wilczewska, K. Niemirowicz, K. H. Markiewicz, et al., Pharmacol. Rep., 64(5), 1020 – 1037 (2012).
C. dos Santos Giuberti, E. C. de Oliveira Reis, T. G. Ribeiro Rocha, et al., J. Liposome Res., 21(1), 60 – 69 (2011).
C. Puglia, A. Offerta, C. Carbone, et al., Curr. Med. Chem., 22(13), 1589 – 1602 (2015).
N. Naseri, H. Valizadeh, and P. Zakeri-Milani, Adv. Pharm. Bull., 5(3), 305 – 313 (2015).
H. Oudghiri-Hassani, S. Rakass, F. T. Al Wadaani, et al., J. Taibah Univ. Sci., 9(4), 508–512 (2018).
M. K. Trivedi, R. M. Tallapragada, A. Branton, et al., Am. J. Nano Res. Appl., 3(6), 94 – 98 (2015).
S. A. Hosseini and R. Saeedi, Bull. Chem. React. Eng. Catal., 12(1), 96 – 105 (2017).
K. K. Bera, R. Majumdar, M. Chakraborty, et al., J. Hazard. Mater., 352, 182 – 191 (2018).
F. Qin, H. Zhao, G. Li, et al., Nanoscale, 6, 5402–5409 (2014).
M. Mallahi, A. Shokuhfar, M. R. Vaezi, et al. AJER, 3(4), 162 – 165 (2014).
T. Rudin, K. Wegnerm and S. E. Pratsinis, J. Nanopart. Res., 13(7), 2715 – 2725 (2011).
S. Park, S. An, H. Ko, et al., J. Nanosci. Nanotechnol., 15(2), 1605 – 1609 (2015).
K. Brezesinski, R. Ostermann, P. Hartmann, et al., Chem. Mater. 22(10), 3079 – 3085 (2010).
J. Wang, X. Yang, K. Zhao, et al., J. Mater. Chem. A, 1(32), 9069 – 9074 (2013).
X. Zhong, Z. Dai, F. Qin, et al., RSC Adv., 5(85), 69312 – 69318 (2015).
R. Hernandez-Delgadillo, D. Velasco-Arias, J. J. Martinez-Sanmiguel, et al., Int. J. Nanomed., 8(1), 1645 – 1652 (2013).
V. A. Ovsyannikov, M. V. Zamoryanskaya, A. V. Semencha, et al., Glass Phys. Chem., 41(5), 533 – 536 (2015).
C. Stewart, K. Konstantinov, S. McKinnon, et al., Phys. Med., 32(11), 1444 – 1452 (2016).
H. Zhu, Y. Li, R. Qiu, et al., Biomaterials, 33(10), 3058 – 3069 (2012).
K. Bogusz, M. Tehei, C. Stewart, et al., RSC Adv., 4(46), 24412 – 24419 (2014).
F. Du, J. Lou, R. Jiang, et al., Int. J. Nanomed., 12, 5973 – 5992 (2017).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Szostak, K., Ostaszewski, P., Pulit-Prociak, J. et al. Bismuth Oxide Nanoparticles in Drug Delivery Systems. Pharm Chem J 53, 48–51 (2019). https://doi.org/10.1007/s11094-019-01954-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-019-01954-9